Pharma BD Deal Intelligence
Valeant Pharmaceuticals International / Xcel Pharmaceuticals, Inc.
2005 · Acquisition/Merger · $280M · Complete
Announcement Sentiment
80
Strongly positive
Valeant acquires Xcel Pharmaceuticals in 2005; brought neurology assets including rights to retigabine/ezogabine.
Key facts
- Announced Feb 15, 2005
- Closed Mar 01, 2005
- Deal value $280M
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals